中東およびアフリカのバイオプロセス市場予測 - 2031年まで - 地域分析 - 製品別（機器および消耗品および付属品）、事業規模別（商業事業および臨床事業）、プロセス別（下流バイオプロセスおよび上流バイオプロセス）、用途別（モノクローナル抗体、ワクチン、組み換えタンパク質、細胞および遺伝子治療など）、およびエンドユーザー別（バイオ医薬品会社、契約製造組織など）
自動化された細胞療法製造への移行が中東およびアフリカのバイオプロセス市場を後押し
細胞療法の増加により、細胞療法製品の生産は世界中で少量から大量へと移行しています。細胞療法の研究活動の増加により、高度な製造ソリューションの需要が高まっています。これを考慮して、多くのプレーヤーが学術研究者や大手バイオテクノロジー企業のニーズを満たす製品を提供しています。たとえば、Lonza CocoonやMiltenyiのCliniMACS Prodigyシステムは、CAR-Tプロセスのほとんどの連続ユニット操作を単一のシステム内で自動化できるように設計されています。さらに、細胞療法の進化（学術および臨床現場から大量生産および商業化へ）により、製造の自動化の需要が高まっています。2019年5月、GEヘルスケアは、細胞療法のワークフロー全体をサポートするクロニクルウェブアプリケーションをリリースしました。クロニクル自動化ソフトウェアは、複雑な細胞療法プロセスの開発と製造を最適化するように設計された、適正製造基準に準拠したデジタルソリューションです。企業は、細胞療法の自動化のための戦略的および技術的開発にも参入しています。たとえば、2020年7月、サーモフィッシャーサイエンティフィック社とライエルイムノファーマ社は、がん患者に効果的な細胞療法を設計するためのプロセスの開発と製造で提携しました。この提携の下、両社はT細胞の適応性を向上させ、試薬、消耗品、機器とともに、統合されたcGMP準拠プラットフォーム（システムとソフトウェア）の開発をサポートすることを目指しています。2019年3月、ロンザはイスラエルのシェバ医療センターと提携し、ポイントオブケアのコクーン細胞療法製造プラットフォームを使用して、自動化されたクローズドCAR-T製造を提供しました。自動化された手順により、製造コストを大幅に削減し、スタッフの生産性と定着率を高めることができます。これらの要因以外にも、自動化されたプロセスは製造ユニット内のさまざまな汚染源を制限し、最終的にはプロセスの一貫性を高め、手作業によるエラーを減らすことで全体的に高品質の製品を生み出します。したがって、細胞療法メーカーによる自動化の採用の増加と細胞療法の分野での製品革新の増加は、細胞療法のバイオプロセスまたは製造を促進する可能性があります。
中東およびアフリカのバイオプロセス市場の概要
中東およびアフリカのバイオプロセス市場は、サウジアラビア、UAE、南アフリカ、およびその他の中東およびアフリカに分割されています。サウジアラビアは、中東およびアフリカで最大の市場シェアを占めています。この地域の市場を牽引するいくつかの要因は、がんの罹患率の増加、免疫疾患の発生率の増加、政府による好ましい取り組み、研究開発活動の急増です。サウジアラビアの省庁は、国内に生産施設を設立するためにバイオテクノロジー企業と契約を結んでいます。これに沿って、国際企業が中東およびアフリカでのプレゼンスを強化するために採用している拡大戦略は、今後数年間でバイオプロセス市場に利益をもたらすと予想されます。
中東およびアフリカのバイオプロセス市場の収益と2031年までの予測（百万米ドル）
中東およびアフリカのバイオプロセス市場のセグメンテーション
中東およびアフリカのバイオプロセス市場は、製品、運用規模、プロセス、アプリケーション、エンドユーザー、および国に分類されています。
製品に基づいて、中東およびアフリカのバイオプロセス市場は、機器と消耗品およびアクセサリに分かれています。 機器セグメントは、2023年に大きな市場シェアを占めました。 さらに、機器セグメントは、ろ過装置、バイオリアクター、クロマトグラフィーシステム、遠心分離機、乾燥装置などにサブセグメント化されています。 さらに、バイオリアクターのサブセグメントは、パイロットスケール、フルスケール、およびラボスケールに分類されます。 さらに、サブセグメントのクロマトグラフィーシステムは、液体クロマトグラフィー、ガスクロマトグラフィーなどにセグメント化されています。さらに、消耗品および付属品セグメントは、試薬、細胞培養培地、クロマトグラフィー樹脂などに細分化されています。
事業規模の面では、中東およびアフリカのバイオプロセシング市場は、商業事業と臨床事業に分かれています。 商業事業セグメントは、2023年に大きな市場シェアを占めました。
プロセス別に見ると、中東およびアフリカのバイオプロセシング市場は、下流バイオプロセスと上流バイオプロセスに分かれています。 下流バイオプロセスセグメントは、2023年に大きな市場シェアを占めました。
用途別に見ると、中東およびアフリカのバイオプロセシング市場は、モノクローナル抗体、ワクチン、組み換えタンパク質、細胞および遺伝子治療などに分類されています。 モノクローナル抗体セグメントは、2023年に最大の市場シェアを占めました。
エンドユーザーの観点から見ると、中東およびアフリカのバイオプロセシング市場は、バイオ医薬品会社、契約製造組織などに分類されています。バイオ医薬品企業セグメントは、2023年に最大の市場シェアを占めました。
国別に見ると、中東およびアフリカのバイオプロセス市場は、サウジアラビア、南アフリカ、UAE、その他の中東およびアフリカに分かれています。サウジアラビアは、2023年に中東およびアフリカのバイオプロセス市場シェアを独占しました。
Getinge AB、Thermo Fisher Scientific Inc、Sartorius AG、Corning Inc、Bio-Rad Laboratories Inc、Merck KGaA、3M Co、Eppendorf SE、Agilent Technologies Inc、およびCytiva US LLCは、中東およびアフリカのバイオプロセス市場で事業を展開している大手企業の一部です。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodologys
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Bioprocessing Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Diseases
4.1.2 Growing Biopharmaceutical Industry
4.2 Market Restraints
4.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
4.3 Market Opportunities
4.3.1 Proliferating Demand for Personalized Medicine
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact of Drivers and Restraints:
5. Bioprocessing Market - Middle East & Africa Analysis
5.1 Middle East & Africa Bioprocessing Market Overview
5.2 Bioprocessing Market Revenue (US$ Million), 2021-2031
6. Middle East & Africa Bioprocessing Market Analysis - by Product
6.1 Overview
6.2 Instruments
6.2.1 Overview
6.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
6.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
6.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
6.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
6.3 Consumables & Accessories
6.3.1 Overview
6.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
6.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
7. Middle East & Africa Bioprocessing Market Analysis - by Scale of Operation
7.1 Overview
7.2 Commercial Operations
7.2.1 Overview
7.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Clinical Operations
7.3.1 Overview
7.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8. Middle East & Africa Bioprocessing Market Analysis - by Process
8.1 Overview
8.2 Downstream Bioprocess
8.2.1 Overview
8.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Upstream Bioprocess
8.3.1 Overview
8.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9. Middle East & Africa Bioprocessing Market Analysis - by Application
9.1 Overview
9.2 Monoclonal Antibodies
9.2.1 Overview
9.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Vaccines
9.3.1 Overview
9.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Recombinant Protein
9.4.1 Overview
9.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Cell & Gene Therapy
9.5.1 Overview
9.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10. Middle East & Africa Bioprocessing Market Analysis - by End User
10.1 Overview
10.2 Biopharmaceutical Companies
10.2.1 Overview
10.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Contract Manufacturing Organization
10.3.1 Overview
10.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11. Middle East & Africa Bioprocessing Market - Country Analysis
11.1 Middle East & Africa
11.1.1 Middle East & Africa: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
11.1.1.1 Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.1.1 Overview
11.1.1.2 Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.2.1 Saudi Arabia: Bioprocessing Market Breakdown, by Product
11.1.1.2.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Instruments
11.1.1.2.1.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.2.1.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.2.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.2.2 Saudi Arabia: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.2.3 Saudi Arabia: Bioprocessing Market Breakdown, by Process
11.1.1.2.4 Saudi Arabia: Bioprocessing Market Breakdown, by Application
11.1.1.2.5 Saudi Arabia: Bioprocessing Market Breakdown, by End User
11.1.1.3 South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.3.1 Overview
11.1.1.4 South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.4.1 South Africa: Bioprocessing Market Breakdown, by Product
11.1.1.4.1.1 South Africa: Bioprocessing Market Breakdown, by Instruments
11.1.1.4.1.1.1 South Africa: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.4.1.1.2 South Africa: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.4.1.2 South Africa: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.4.2 South Africa: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.4.3 South Africa: Bioprocessing Market Breakdown, by Process
11.1.1.4.4 South Africa: Bioprocessing Market Breakdown, by Application
11.1.1.4.5 South Africa: Bioprocessing Market Breakdown, by End User
11.1.1.5 United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.5.1 Overview
11.1.1.6 United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.6.1 United Arab Emirates: Bioprocessing Market Breakdown, by Product
11.1.1.6.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Instruments
11.1.1.6.1.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.6.1.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.6.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.6.2 United Arab Emirates: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.6.3 United Arab Emirates: Bioprocessing Market Breakdown, by Process
11.1.1.6.4 United Arab Emirates: Bioprocessing Market Breakdown, by Application
11.1.1.6.5 United Arab Emirates: Bioprocessing Market Breakdown, by End User
11.1.1.7 Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.7.1 Overview
11.1.1.8 Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1.8.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Product
11.1.1.8.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Instruments
11.1.1.8.1.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Bioreactors
11.1.1.8.1.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Chromatography Systems
11.1.1.8.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Consumables & Accessories
11.1.1.8.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Scale of Operation
11.1.1.8.3 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Process
11.1.1.8.4 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Application
11.1.1.8.5 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Bioprocessing Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Getinge AB
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sartorius AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Corning Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio-Rad Laboratories Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Merck KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 3M Co
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eppendorf SE
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Agilent Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Cytiva US LLC
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
?
List of Tables
Table 1. Middle East & Africa Bioprocessing Market Segmentation
Table 2. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 6. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 7. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 8. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 9. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 10. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 11. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 12. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 13. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 14. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 15. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 16. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 17. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 18. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 19. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 20. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 21. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 22. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 23. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 24. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 25. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 26. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 27. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 28. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 29. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 30. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 31. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 32. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 33. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 34. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 35. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 36. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 37. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 38. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 39. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 40. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 41. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 42. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 43. Recent Organic Growth Strategies in the Bioprocessing Market
Table 44. Glossary of Terms, Bioprocessing Market
?
List of Figures
Figure 1. Middle East & Africa Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Middle East & Africa: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. Middle East & Africa: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Growth Strategies in the Bioprocessing Market
- Getinge AB
- Thermo Fisher Scientific Inc
- Sartorius AG
- Corning Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- 3M Co
- Eppendorf SE
- Agilent Technologies Inc
- Cytiva US LLC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa bioprocessing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa bioprocessing market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.